How Bad Is 8 Prostate Cancer
Published on May 29 2010, in the categories: Problems
Each cancer is unique and different patients may report different symptoms in different stages in different periods of time; the prostate cancer has no early signs to make it noticeable in its first stages but there are some common reported symptoms which tend to appear soon after starting its spreading. If any unusual symptoms are noticed without any specific and unidentified cause then the screening tests are recommended. No matter how old this approach of identifying the prostate cancer in its early stages may be the screening tests still remain popular.
<-336x280 Large Rectangle - center->
Usually, the spreading process is done by invading the surrounding areas of the prostate, in the first stages the cancer becoming locally advanced and without any proper treatment the cancer will soon become metastatic; that basically means that the cancer cells started their travel to other far regions of the organism through the bloodstream and the lymph system and made possible the apparition of other small, secondary malignant tumors which can infect vital organs such as the lungs or brain.
Cancer is seen as an abnormal medical condition having as main causes some factors such as the genetic inheritance, because cancer can be inherited by the members of the same family, the aging process, the working environment, alimentation, excessive alcohol drinking and smoking or even race.
The causes mentioned above allow the multiplication and the fast spreading of the cancer cells, first in the infected organ and only after in the entire body. The normal apoptotic reaction and the mitosis fail to function well and because of that the primary tumor slowly increases in size and eventually reaches outside the organ confined site. With these features we can also describe the cancer that affects the male specific gland responsible with the making of the seminal fluid, the prostate.
Usually the prognosis has two results: the patient will respond well to the treatment or the prescribed treatment will prove ineffective in stopping or even delaying the spreading of the tumor. The prognosis is usually challenging just because its results are relative, depending very much on the uniqueness of each cancer but the mortality charts offer some answers about the chances of survival and how will a prostate cancer above a bad grade such as the eight grade for example, will affect the health of that certain patient.
The screening includes the digital rectal examination done by a medical specialist that determines any abnormality with the size of the prostate gland by inserting a gloved finger into the rectum and palpating the presumably infected organ; the prostate specific antigen blood test indicates the levels of the prostate specific antigen protein which in normal circumstances should be low. The results of these tests have to be interpreted by doctors; they will also be responsible for the decision to continue with the medical investigations or not.
With the help of the prostate biopsy the future diagnose will be as accurate as it can be, especially if this method of detection is complemented by newer ones such as the nomogram or the prostate mapping.
If cancer is detected the main problem will be to answer the question of how bad is eight prostate cancer. First, the characteristics of the prostate cancer will be determined with the grading and staging systems such as the Gleason scale and the TNM (tumor, nodes and metastatic) staging system or its alternative, the Whitmore-Jewett system.
The Gleason score or the sum of primary grade or the majority of the tumor and the secondary grade or the minority of the tumor is different from the Gleason grade, whose numbers range between two and ten, the scores between seven and ten indicating a rapid growing tumor. Usually the higher a score is the more aggressive a cancer can get so it is very important to make an accurate prognosis about the outcome of the prostate cancer and determine approximately how long men with a bad eight grade prostate cancer will get to live.
After fifteen years the survival rates tend to stabilize and the life expectancies can increase even if the cancer is locally advanced but for the metastatic cancer, the average time of survival is one to three years after the initial diagnose and sometimes the patient will die because of some other health complications.
To prolong the chances of survival for men with advanced prostate cancer the recommended treatments are the radiotherapy, the androgen deprivation therapy and chemotherapy, complemented by the use of strong drugs to increase the treatment’s effectiveness.
<-336x280 Large Rectangle - center->
Usually, the spreading process is done by invading the surrounding areas of the prostate, in the first stages the cancer becoming locally advanced and without any proper treatment the cancer will soon become metastatic; that basically means that the cancer cells started their travel to other far regions of the organism through the bloodstream and the lymph system and made possible the apparition of other small, secondary malignant tumors which can infect vital organs such as the lungs or brain.
Cancer is seen as an abnormal medical condition having as main causes some factors such as the genetic inheritance, because cancer can be inherited by the members of the same family, the aging process, the working environment, alimentation, excessive alcohol drinking and smoking or even race.
The causes mentioned above allow the multiplication and the fast spreading of the cancer cells, first in the infected organ and only after in the entire body. The normal apoptotic reaction and the mitosis fail to function well and because of that the primary tumor slowly increases in size and eventually reaches outside the organ confined site. With these features we can also describe the cancer that affects the male specific gland responsible with the making of the seminal fluid, the prostate.
Usually the prognosis has two results: the patient will respond well to the treatment or the prescribed treatment will prove ineffective in stopping or even delaying the spreading of the tumor. The prognosis is usually challenging just because its results are relative, depending very much on the uniqueness of each cancer but the mortality charts offer some answers about the chances of survival and how will a prostate cancer above a bad grade such as the eight grade for example, will affect the health of that certain patient.
The screening includes the digital rectal examination done by a medical specialist that determines any abnormality with the size of the prostate gland by inserting a gloved finger into the rectum and palpating the presumably infected organ; the prostate specific antigen blood test indicates the levels of the prostate specific antigen protein which in normal circumstances should be low. The results of these tests have to be interpreted by doctors; they will also be responsible for the decision to continue with the medical investigations or not.
With the help of the prostate biopsy the future diagnose will be as accurate as it can be, especially if this method of detection is complemented by newer ones such as the nomogram or the prostate mapping.
If cancer is detected the main problem will be to answer the question of how bad is eight prostate cancer. First, the characteristics of the prostate cancer will be determined with the grading and staging systems such as the Gleason scale and the TNM (tumor, nodes and metastatic) staging system or its alternative, the Whitmore-Jewett system.
The Gleason score or the sum of primary grade or the majority of the tumor and the secondary grade or the minority of the tumor is different from the Gleason grade, whose numbers range between two and ten, the scores between seven and ten indicating a rapid growing tumor. Usually the higher a score is the more aggressive a cancer can get so it is very important to make an accurate prognosis about the outcome of the prostate cancer and determine approximately how long men with a bad eight grade prostate cancer will get to live.
After fifteen years the survival rates tend to stabilize and the life expectancies can increase even if the cancer is locally advanced but for the metastatic cancer, the average time of survival is one to three years after the initial diagnose and sometimes the patient will die because of some other health complications.
To prolong the chances of survival for men with advanced prostate cancer the recommended treatments are the radiotherapy, the androgen deprivation therapy and chemotherapy, complemented by the use of strong drugs to increase the treatment’s effectiveness.
How Long Do Men With Advanced Prostate Cancer Live
Published on May 29 2010, in the categories: Statistics of Survival Rates
Cancer is seen as an abnormal medical condition having as main causes some factors such as the genetic inheritance, because cancer can be inherited by the members of the same family, the aging process, the working environment, alimentation, excessive alcohol drinking and smoking or even race.
<-336x280 Large Rectangle - center->
The causes mentioned above allow the multiplication and the fast spreading of the cancer cells, first in the infected organ and only after in the entire body. The normal apoptotic reaction and the mitosis fail to function well and because of that the primary tumor slowly increases in size and eventually reaches outside the organ confined site. With these features we can also describe the cancer that affects the male specific gland responsible with the making of the seminal fluid, the prostate.
Usually, the spreading process is done by invading the surrounding areas of the prostate, in the first stages the cancer becoming locally advanced and without any proper treatment the cancer will soon become metastatic; that basically means that the cancer cells started their travel to other far regions of the organism through the bloodstream and the lymph system and made possible the apparition of other small, secondary malignant tumors which can infect vital organs such as the lungs or brain.
Each cancer is unique and different patients may report different symptoms in different stages in different periods of time; the prostate cancer has no early signs to make it noticeable in its first stages but there are some common reported symptoms which tend to appear soon after starting its spreading. If any unusual symptoms are noticed without any specific and unidentified cause then the screening tests are recommended. No matter how old this approach of identifying the prostate cancer in its early stages may be the screening tests still remain popular.
The screening includes the digital rectal examination done by a medical specialist that determines any abnormality with the size of the prostate gland by inserting a gloved finger into the rectum and palpating the presumably infected organ; the prostate specific antigen blood test indicates the levels of the prostate specific antigen protein which in normal circumstances should be low. The results of these tests have to be interpreted by doctors; they will also be responsible for the decision to continue with the medical investigations or not.
With the help of the prostate biopsy the future diagnose will be as accurate as it can be, especially if this method of detection is complemented by newer ones such as the nomogram or the prostate mapping.
If cancer is detected the main problem will be to answer the question of how long do men with advanced prostate cancer get to live. First, the characteristics of the prostate cancer will be determined with the grading and staging systems such as the Gleason scale and the TNM (tumor, nodes and metastatic) staging system or its alternative, the Whitmore-Jewett system.
Usually the higher a score is the more aggressive a cancer can get so it is very important to make an accurate prognosis about the outcome of the prostate cancer and determine approximately how long men could live with an advance prostate cancer.
Usually the prognosis has two results: the patient will respond well to the treatment or the prescribed treatment will prove ineffective in stopping or even delaying the spreading of the tumor. The prognosis is usually challenging just because its results are relative,
depending very much on the uniqueness of each cancer but the mortality charts offer some answers about the chances of survival and for how long a patient gets to live if he is diagnosed with an advanced prostate cancer.
Even after the five year survival rate a possibility of cancer recurrence will always remain, sometimes coming back in more aggressive forms such as the metastases or two or more metastatic tumors, affecting gravely the bone system and other important organs.
To prolong the chances of survival or living for men with advanced prostate cancer the recommended treatments are the radiotherapy, brachytherapy or proton beam therapy, the androgen deprivation therapy or the hormone therapy and chemotherapy, complemented by the use of strong drugs to increase the treatment’s effectiveness.
After fifteen years the survival rates tend to stabilize and the life expectancies can increase even if the cancer is locally advanced but for the metastatic cancer, the average time of survival is one to three years after the initial diagnose and sometimes the patient will die because of some other health complications.
<-336x280 Large Rectangle - center->
The causes mentioned above allow the multiplication and the fast spreading of the cancer cells, first in the infected organ and only after in the entire body. The normal apoptotic reaction and the mitosis fail to function well and because of that the primary tumor slowly increases in size and eventually reaches outside the organ confined site. With these features we can also describe the cancer that affects the male specific gland responsible with the making of the seminal fluid, the prostate.
Usually, the spreading process is done by invading the surrounding areas of the prostate, in the first stages the cancer becoming locally advanced and without any proper treatment the cancer will soon become metastatic; that basically means that the cancer cells started their travel to other far regions of the organism through the bloodstream and the lymph system and made possible the apparition of other small, secondary malignant tumors which can infect vital organs such as the lungs or brain.
Each cancer is unique and different patients may report different symptoms in different stages in different periods of time; the prostate cancer has no early signs to make it noticeable in its first stages but there are some common reported symptoms which tend to appear soon after starting its spreading. If any unusual symptoms are noticed without any specific and unidentified cause then the screening tests are recommended. No matter how old this approach of identifying the prostate cancer in its early stages may be the screening tests still remain popular.
The screening includes the digital rectal examination done by a medical specialist that determines any abnormality with the size of the prostate gland by inserting a gloved finger into the rectum and palpating the presumably infected organ; the prostate specific antigen blood test indicates the levels of the prostate specific antigen protein which in normal circumstances should be low. The results of these tests have to be interpreted by doctors; they will also be responsible for the decision to continue with the medical investigations or not.
With the help of the prostate biopsy the future diagnose will be as accurate as it can be, especially if this method of detection is complemented by newer ones such as the nomogram or the prostate mapping.
If cancer is detected the main problem will be to answer the question of how long do men with advanced prostate cancer get to live. First, the characteristics of the prostate cancer will be determined with the grading and staging systems such as the Gleason scale and the TNM (tumor, nodes and metastatic) staging system or its alternative, the Whitmore-Jewett system.
Usually the higher a score is the more aggressive a cancer can get so it is very important to make an accurate prognosis about the outcome of the prostate cancer and determine approximately how long men could live with an advance prostate cancer.
Usually the prognosis has two results: the patient will respond well to the treatment or the prescribed treatment will prove ineffective in stopping or even delaying the spreading of the tumor. The prognosis is usually challenging just because its results are relative,
depending very much on the uniqueness of each cancer but the mortality charts offer some answers about the chances of survival and for how long a patient gets to live if he is diagnosed with an advanced prostate cancer.
Even after the five year survival rate a possibility of cancer recurrence will always remain, sometimes coming back in more aggressive forms such as the metastases or two or more metastatic tumors, affecting gravely the bone system and other important organs.
To prolong the chances of survival or living for men with advanced prostate cancer the recommended treatments are the radiotherapy, brachytherapy or proton beam therapy, the androgen deprivation therapy or the hormone therapy and chemotherapy, complemented by the use of strong drugs to increase the treatment’s effectiveness.
After fifteen years the survival rates tend to stabilize and the life expectancies can increase even if the cancer is locally advanced but for the metastatic cancer, the average time of survival is one to three years after the initial diagnose and sometimes the patient will die because of some other health complications.
Mortality Charts For Prostate Cancer
Published on May 28 2010, in the categories: Statistics of Survival Rates
The mortality charts based on annual information about the survival rates from prostate cancer indicate a large number of deaths caused by this type of cancer, although the newer methods of detection prove to be more efficient in establishing a correct diagnose.
<-336x280 Large Rectangle - center->
That doesn’t necessarily mean that the screening tests are inefficient. In fact, the screening tests only indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.
In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.
As old as it may be, the screening test still remains the best method of detecting the cancer in its early stages.
For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.
Based on the charts of prostate cancer mortality the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.
Cancer is seen as an abnormal condition having as main causes some factors such as the working environment and the alimentation, the smoking or excessive alcohol drinking, the ageing process, the genetic inheritance since cancer can be inherited via the members of a family and even race. These factors allow the fast development or multiplication of the cancer cells while the normal ones experience a rapid death because of the malfunctioning of the apoptotic reaction and the mitosis.
The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.
The mortality statistic charts help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.
Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.
In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.
The fifteen year survival rate is of about seventy six percent but if the cancer becomes locally advance or metastatic, life can be prolonged only with the help of some strong and effective treatment such as the hormone therapy or radiotherapy.
The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the mortality charts can only increase the angst and the depressive moods of a patient if they are revealed.
For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.
<-336x280 Large Rectangle - center->
That doesn’t necessarily mean that the screening tests are inefficient. In fact, the screening tests only indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.
In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.
As old as it may be, the screening test still remains the best method of detecting the cancer in its early stages.
For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.
Based on the charts of prostate cancer mortality the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.
Cancer is seen as an abnormal condition having as main causes some factors such as the working environment and the alimentation, the smoking or excessive alcohol drinking, the ageing process, the genetic inheritance since cancer can be inherited via the members of a family and even race. These factors allow the fast development or multiplication of the cancer cells while the normal ones experience a rapid death because of the malfunctioning of the apoptotic reaction and the mitosis.
The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.
The mortality statistic charts help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.
Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.
In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.
The fifteen year survival rate is of about seventy six percent but if the cancer becomes locally advance or metastatic, life can be prolonged only with the help of some strong and effective treatment such as the hormone therapy or radiotherapy.
The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the mortality charts can only increase the angst and the depressive moods of a patient if they are revealed.
For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.
Prostate Cancer Statistics
Published on May 28 2010, in the categories: prostate cancer, Statistics of Survival Rates
Cancer is seen as an abnormal condition having as main causes some factors such as the working environment and the alimentation, the smoking or excessive alcohol drinking, the aging process, the genetic inheritance since cancer can be inherited via the members of a family and even race. These factors allow the fast development or multiplication of the cancer cells while the normal ones experience a rapid death because of the malfunctioning of the apoptotic reaction and the mitosis.
<-336x280 Large Rectangle - center->
In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.
The screening tests indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.
For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.
The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the prostate cancer world wide statistics can only increase the angst and the depressive moods of a patient if they are revealed.
For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.
In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.
The mortality statistics for prostate cancer patients help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.
Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.
Based on certain surveys or statistics of prostate cancer the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.
The statistics about the prostate cancer based on annual information about the survival rates indicate a large number of deaths caused by this type of cancer, although the newer methods of detection prove to be more efficient in establishing a correct diagnose.
The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.
<-336x280 Large Rectangle - center->
In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.
The screening tests indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.
For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.
The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the prostate cancer world wide statistics can only increase the angst and the depressive moods of a patient if they are revealed.
For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.
In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.
The mortality statistics for prostate cancer patients help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.
Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.
Based on certain surveys or statistics of prostate cancer the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.
The statistics about the prostate cancer based on annual information about the survival rates indicate a large number of deaths caused by this type of cancer, although the newer methods of detection prove to be more efficient in establishing a correct diagnose.
The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.
Diindolylmethane For Prostate Cancer
Published on May 27 2010, in the categories: treatment
3,3′-Diindolylmethane or DIM used for treating prostate cancer is an anticarcinogen natural compound formed during the autolytic breakdown of glucobrassicin and derived from the digestion of indole-3-carbinol found in plant from the Brassica genus which includes vegetables such as cauliflower, broccoli, cabbage, kale, Brussels sprouts and collard greens.
<-336x280 Large Rectangle - center->
The prognosis for the outcome of the prostate cancer is rather pessimistic and several research studies have shown that despite the treatment discoveries announced almost every year, the prostate cancer still remains the most common type of cancer which affects the male population from all around the world, with one in six men diagnosed with a prostate cancer.
In America only the lung cancer is to be blamed for the numerous reported deaths followed immediately by the prostate cancer.
Still though, if this cancer is detected in its early stages with the help of the regularly screening tests, there is a ninety eight percent chance of five year survival after the initial diagnose and the results tend to stabilize after reaching a fifteen year survival rate.
Several factors are to be held responsible for allowing the apparition and progression of a prostate cancer such as age, the working environment, the foods one consumes after a certain age, race and genetic inheritance, etc.
Cancer is seen as an abnormal condition having as main causes the factors mentioned before which allow the multiplication and fast development of the cancer cells and malignant tumors and prevent the well functioning of the apoptotic reaction and the mitosis; each cancer is unique and that means that the same type of cancer can have different characteristics reported in different patients.
In different people the cancer can progress at different stages in different periods of time with different consequences and treatment effects; this whole thing makes the prognosis rather difficult and relative.
The spreading process is done through the lymph system and vessels and bloodstream and can take several years for the tumor to reach outside the prostate capsule and reach the surrounding areas such as the liver and the bladder, becoming locally advanced, or infecting far distance regions of the body such as the bone system and affecting vital organs such as the lungs and brain: this is the stage of metastatic cancer.
The stages of the cancer can be determined with the available staging systems such as the Whitmore-Jewett system or the TNM or tumor, nodes and metastatic system.
The grading is also done with the Gleason scale, which is not the only available system but it is certainly the most popular one. This whole activity of grading and staging is done only if cancer is diagnosed with the help of the screening tests or the prostate biopsy.
The results of the screening tests are interpreted by doctors because they don’t offer an accurate result whether cancer exists or not; with the digital rectal exam the physician can only palpate de size of the prostate and sense any abnormality with it and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal conditions.
The prostate biopsy, complemented by the nomogram or the prostate mapping, is the best method of detection and can give an accurate diagnose.
The patient can respond well to a correct prescribed treatment and the fortunate fact is that if the cancer is detected early those treatments can prevent or even stop the progression of cancer, mostly because of its slow growth, in general the tumor doubling its size once every four years. Those treatments can be complemented with the use of strong drugs or other medical or mineral supplements.
DIM is often used for treating viral infections and is used as an antibiotic-resistant bacteria but the National Cancer Institute of the United States began testing the diindolylmethane for the anti-prostate cancer properties by conducting several research studies in therapies for numerous types of cancer, including the prostate cancer.
These studies also have shown some complex interactions of DIM with the hormone estrogen, by blocking the effects of this hormone on the cells, which could lead to either negative or positive effects on cancer risks. This compound can also affect the balance of the testosterone levels but the effects of diindolylmethane in prostate cancer are still not fully understood.
The optimal dose for DIM is still not known but although it is a nontoxic substance, manufacturers that sell the diindolylmethane for prostate cancer recommend between 500 to 1000 mg daily.
<-336x280 Large Rectangle - center->
The prognosis for the outcome of the prostate cancer is rather pessimistic and several research studies have shown that despite the treatment discoveries announced almost every year, the prostate cancer still remains the most common type of cancer which affects the male population from all around the world, with one in six men diagnosed with a prostate cancer.
In America only the lung cancer is to be blamed for the numerous reported deaths followed immediately by the prostate cancer.
Still though, if this cancer is detected in its early stages with the help of the regularly screening tests, there is a ninety eight percent chance of five year survival after the initial diagnose and the results tend to stabilize after reaching a fifteen year survival rate.
Several factors are to be held responsible for allowing the apparition and progression of a prostate cancer such as age, the working environment, the foods one consumes after a certain age, race and genetic inheritance, etc.
Cancer is seen as an abnormal condition having as main causes the factors mentioned before which allow the multiplication and fast development of the cancer cells and malignant tumors and prevent the well functioning of the apoptotic reaction and the mitosis; each cancer is unique and that means that the same type of cancer can have different characteristics reported in different patients.
In different people the cancer can progress at different stages in different periods of time with different consequences and treatment effects; this whole thing makes the prognosis rather difficult and relative.
The spreading process is done through the lymph system and vessels and bloodstream and can take several years for the tumor to reach outside the prostate capsule and reach the surrounding areas such as the liver and the bladder, becoming locally advanced, or infecting far distance regions of the body such as the bone system and affecting vital organs such as the lungs and brain: this is the stage of metastatic cancer.
The stages of the cancer can be determined with the available staging systems such as the Whitmore-Jewett system or the TNM or tumor, nodes and metastatic system.
The grading is also done with the Gleason scale, which is not the only available system but it is certainly the most popular one. This whole activity of grading and staging is done only if cancer is diagnosed with the help of the screening tests or the prostate biopsy.
The results of the screening tests are interpreted by doctors because they don’t offer an accurate result whether cancer exists or not; with the digital rectal exam the physician can only palpate de size of the prostate and sense any abnormality with it and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal conditions.
The prostate biopsy, complemented by the nomogram or the prostate mapping, is the best method of detection and can give an accurate diagnose.
The patient can respond well to a correct prescribed treatment and the fortunate fact is that if the cancer is detected early those treatments can prevent or even stop the progression of cancer, mostly because of its slow growth, in general the tumor doubling its size once every four years. Those treatments can be complemented with the use of strong drugs or other medical or mineral supplements.
DIM is often used for treating viral infections and is used as an antibiotic-resistant bacteria but the National Cancer Institute of the United States began testing the diindolylmethane for the anti-prostate cancer properties by conducting several research studies in therapies for numerous types of cancer, including the prostate cancer.
These studies also have shown some complex interactions of DIM with the hormone estrogen, by blocking the effects of this hormone on the cells, which could lead to either negative or positive effects on cancer risks. This compound can also affect the balance of the testosterone levels but the effects of diindolylmethane in prostate cancer are still not fully understood.
The optimal dose for DIM is still not known but although it is a nontoxic substance, manufacturers that sell the diindolylmethane for prostate cancer recommend between 500 to 1000 mg daily.
Radar Prostate Cancer Zoledronic Acid
Published on May 27 2010, in the categories: Related topics
The zoledronic acid or zoledronate is a bisphosphonate, marketed by Novartis under the trade names of Zomera, Aclasta, Zometa and Reclast and it is recommended for preventing skeletal fractures in patients with bone metastases, cause mainly by diseases such as the prostate cancer and multiple myeloma. The effects of zoledronic acid on prostate cancer are still under study but the certain fact is that this compound can treat osteoporosis and is processed via the kidneys, so it is contraindicated for pregnancy, hipocalcemia, paralysis and poor renal function.
<-336x280 Large Rectangle - center->
Cancer is seen as an abnormal condition having as main causes the factors mentioned before which allow the multiplication and fast development of the cancer cells and malignant tumors and prevent the well functioning of the apoptotic reaction and the mitosis; each cancer is unique and that means that the same type of cancer can have different characteristics reported in different patients.
In America only the lung cancer is to be blamed for the numerous reported deaths followed immediately by the prostate cancer.
The prognosis for the outcome of the prostate cancer is rather pessimistic and several research studies have shown that despite the treatment discoveries announced almost every year, the prostate cancer still remains the most common type of cancer which affects the male population from all around the world, with one in six men diagnosed with a prostate cancer.
Several factors are to be held responsible for allowing the apparition and progression of a prostate cancer such as age, the working environment, the foods one consumes after a certain age, race and genetic inheritance, etc.
In different people the cancer can progress at different stages in different periods of time with different consequences and treatment effects; this whole thing makes the prognosis rather difficult and relative.
The results of the screening tests are interpreted by doctors because they don’t offer an accurate result whether cancer exists or not; with the digital rectal exam the physician can only palpate de size of the prostate and sense any abnormality with it and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal conditions.
The prostate biopsy, complemented by the nomogram or the prostate mapping, is the best method of detection and can give an accurate diagnose.
The grading is also done with the Gleason scale, which is not the only available system but it is certainly the most popular one. This whole activity of grading and staging is done only if cancer is diagnosed with the help of the screening tests or the prostate biopsy.
The stages of the cancer can be determined with the available staging systems such as the Whitmore-Jewett system or the TNM or tumor, nodes and metastatic system.
The patient can respond well to a correct prescribed treatment and the fortunate fact is that if the cancer is detected early those treatments can prevent or even stop the progression of cancer, mostly because of its slow growth, in general the tumor doubling its size once every four years. Those treatments can be complemented with the use of strong drugs or other medical or mineral supplements.
The spreading process is done through the lymph system and vessels and bloodstream and can take several years for the tumor to reach outside the prostate capsule and reach the surrounding areas such as the liver and the bladder, becoming locally advanced, or infecting far distance regions of the body such as the bone system and affecting vital organs such as the lungs and brain: this is the stage of metastatic cancer.
Bone metastases caused by the prostate cancer can be treated with the zoledronic acid in certain recommended quantities or doses.
The standard dose of zoledornic acid for prostate cancer patients is four mg infused intravenously every three or four weeks.
The signs and symptoms of the zoledronic acid in prostate cancer are fever, anemia, muscle aches, fatigue, swelling in the legs, flu-like symptoms, etc.
<-336x280 Large Rectangle - center->
Cancer is seen as an abnormal condition having as main causes the factors mentioned before which allow the multiplication and fast development of the cancer cells and malignant tumors and prevent the well functioning of the apoptotic reaction and the mitosis; each cancer is unique and that means that the same type of cancer can have different characteristics reported in different patients.
In America only the lung cancer is to be blamed for the numerous reported deaths followed immediately by the prostate cancer.
The prognosis for the outcome of the prostate cancer is rather pessimistic and several research studies have shown that despite the treatment discoveries announced almost every year, the prostate cancer still remains the most common type of cancer which affects the male population from all around the world, with one in six men diagnosed with a prostate cancer.
Several factors are to be held responsible for allowing the apparition and progression of a prostate cancer such as age, the working environment, the foods one consumes after a certain age, race and genetic inheritance, etc.
In different people the cancer can progress at different stages in different periods of time with different consequences and treatment effects; this whole thing makes the prognosis rather difficult and relative.
The results of the screening tests are interpreted by doctors because they don’t offer an accurate result whether cancer exists or not; with the digital rectal exam the physician can only palpate de size of the prostate and sense any abnormality with it and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal conditions.
The prostate biopsy, complemented by the nomogram or the prostate mapping, is the best method of detection and can give an accurate diagnose.
The grading is also done with the Gleason scale, which is not the only available system but it is certainly the most popular one. This whole activity of grading and staging is done only if cancer is diagnosed with the help of the screening tests or the prostate biopsy.
The stages of the cancer can be determined with the available staging systems such as the Whitmore-Jewett system or the TNM or tumor, nodes and metastatic system.
The patient can respond well to a correct prescribed treatment and the fortunate fact is that if the cancer is detected early those treatments can prevent or even stop the progression of cancer, mostly because of its slow growth, in general the tumor doubling its size once every four years. Those treatments can be complemented with the use of strong drugs or other medical or mineral supplements.
The spreading process is done through the lymph system and vessels and bloodstream and can take several years for the tumor to reach outside the prostate capsule and reach the surrounding areas such as the liver and the bladder, becoming locally advanced, or infecting far distance regions of the body such as the bone system and affecting vital organs such as the lungs and brain: this is the stage of metastatic cancer.
Bone metastases caused by the prostate cancer can be treated with the zoledronic acid in certain recommended quantities or doses.
The standard dose of zoledornic acid for prostate cancer patients is four mg infused intravenously every three or four weeks.
The signs and symptoms of the zoledronic acid in prostate cancer are fever, anemia, muscle aches, fatigue, swelling in the legs, flu-like symptoms, etc.
Folic Acid Contraindicated For Prostate Cancer
Published on May 26 2010, in the categories: Related Diet
The prognosis for the outcome of the prostate cancer is not that optimistic. The prostate cancer still remains the second most dangerous type of cancer, in America only the lung cancer causes more deaths while all around the world, each year, one in six men gets to be diagnosed with a prostate cancer.
<-336x280 Large Rectangle - center->
Cancer is regarded as an abnormal medical condition, developing because of the heavy influence of certain factors that allow the multiplication of the cancer cells and the bad functioning of the mitosis and the apoptotic reaction.
The cancerous cells tend to outlive the normal cells and cause their rapid death; a primary tumor is, in the first stages of cancer, organ-confined but without any proper treatment it will eventually spread to some other surrounding areas or to far distance regions of the body and create some other small and secondary tumors.
The spreading process is rather slow, the tumor doubling its size once every four years and because of this, the survival rate of five years after the initial diagnose is of about ninety eight percent.
These general features of cancer also describe the prostate cancer. The spreading process is done through the lymph system and bloodstream and the malignant tumor can be detected in the early stages only with the help of the screening tests and for a more accurate result, the prostate biopsy.
The screening tests include the digital rectal exam, an examination which sounds and is rather unpleasant but accurate enough to determine the size of the prostate and the prostate specific antigen blood test which is a tumor marker and indicates the levels of the prostate specific antigen which should be low in normal circumstances. The results of the screening tests have to be interpreted by doctors and depending on them, the medical specialist will recommend some future investigations.
This is the moment when the prostate biopsy comes in handy, complemented by some newer methods of detection such as the nomogram or the prostate mapping. If cancer is diagnosed, the grading process and the staging system such as the TNM, tumor, nodes and metastatic system or its alternative, the Whitmore-Jewett staging system, will help determine the exact characteristics of the identified prostate cancer, because it is well known the fact that each cancer is unique, even though you are referring to the same type of cancer.
There are certain factors such as the genetic inheritance, age, race, working environment, alimentation that are to be blamed for the apparition of a prostate cancer and because of that the same type of cancer will develop at different stages, in different periods of time with some different treatment results or medical side-effects in different people.
Certain studies have shown that the folic acid can increase and even double the risk of developing a prostate cancer.
Treatments with aspirin alone had no significant effect on the incidence of prostate cancer but the folic acid increased the risk of prostate cancer with about one hundred and sixty three percent.
The study was published in an editorial issue of the Journal of the National Cancer Institute and the result obtained after analyzing the effect of supplements on the prostate cancer wasn’t optimistic at all.
The folic acid is also know as Pteroylglutamic acid, Folate, Vitamin B9 or Folacin and is a B vitamin that helps to body in making new and healthy cells. This vitamin is very important especially for pregnant women because it can prevent major birth defects of a baby’s spine or brain but in general, everyone needs folic acid.
The food products that contain certain amount of folate are the leafy vegetables such as asparagus and spinach, dried or fresh beans, lentils, peas, liver products, cereals and breakfast cereals and pasta, sunflower seeds, broccoli, lettuce, orange juice, tomato juice, beer, grapefruit, raspberry, strawberry, corn, etc.
Seek for a doctor’s advice and consult him about what foods should be avoided if a prostate cancer is diagnosed and on what products should you built yourself a future nutritional diet.
<-336x280 Large Rectangle - center->
Cancer is regarded as an abnormal medical condition, developing because of the heavy influence of certain factors that allow the multiplication of the cancer cells and the bad functioning of the mitosis and the apoptotic reaction.
The cancerous cells tend to outlive the normal cells and cause their rapid death; a primary tumor is, in the first stages of cancer, organ-confined but without any proper treatment it will eventually spread to some other surrounding areas or to far distance regions of the body and create some other small and secondary tumors.
The spreading process is rather slow, the tumor doubling its size once every four years and because of this, the survival rate of five years after the initial diagnose is of about ninety eight percent.
These general features of cancer also describe the prostate cancer. The spreading process is done through the lymph system and bloodstream and the malignant tumor can be detected in the early stages only with the help of the screening tests and for a more accurate result, the prostate biopsy.
The screening tests include the digital rectal exam, an examination which sounds and is rather unpleasant but accurate enough to determine the size of the prostate and the prostate specific antigen blood test which is a tumor marker and indicates the levels of the prostate specific antigen which should be low in normal circumstances. The results of the screening tests have to be interpreted by doctors and depending on them, the medical specialist will recommend some future investigations.
This is the moment when the prostate biopsy comes in handy, complemented by some newer methods of detection such as the nomogram or the prostate mapping. If cancer is diagnosed, the grading process and the staging system such as the TNM, tumor, nodes and metastatic system or its alternative, the Whitmore-Jewett staging system, will help determine the exact characteristics of the identified prostate cancer, because it is well known the fact that each cancer is unique, even though you are referring to the same type of cancer.
There are certain factors such as the genetic inheritance, age, race, working environment, alimentation that are to be blamed for the apparition of a prostate cancer and because of that the same type of cancer will develop at different stages, in different periods of time with some different treatment results or medical side-effects in different people.
Certain studies have shown that the folic acid can increase and even double the risk of developing a prostate cancer.
Treatments with aspirin alone had no significant effect on the incidence of prostate cancer but the folic acid increased the risk of prostate cancer with about one hundred and sixty three percent.
The study was published in an editorial issue of the Journal of the National Cancer Institute and the result obtained after analyzing the effect of supplements on the prostate cancer wasn’t optimistic at all.
The folic acid is also know as Pteroylglutamic acid, Folate, Vitamin B9 or Folacin and is a B vitamin that helps to body in making new and healthy cells. This vitamin is very important especially for pregnant women because it can prevent major birth defects of a baby’s spine or brain but in general, everyone needs folic acid.
The food products that contain certain amount of folate are the leafy vegetables such as asparagus and spinach, dried or fresh beans, lentils, peas, liver products, cereals and breakfast cereals and pasta, sunflower seeds, broccoli, lettuce, orange juice, tomato juice, beer, grapefruit, raspberry, strawberry, corn, etc.
Seek for a doctor’s advice and consult him about what foods should be avoided if a prostate cancer is diagnosed and on what products should you built yourself a future nutritional diet.
Give Information On Uric Acid In Prostate Cancer
Published on May 26 2010, in the categories: prostate cancer, Related topics
The uric acid is a chemical created whenever the body breaks down substances known as purines; the uric acid travels to the kidneys and a great part of it is dissolved in blood, eventually being passed out in urine.
<-336x280 Large Rectangle - center->
If the uric acid is produced in high levels, a situation known as hyperuricemia, and if it is not removed enough of it will lead to the apparition of certain diseases. Several blood tests indicate the potential level of the uric acid in the body. The normal values of the amount of uric acid identified with the blood tests may vary slightly from laboratory to laboratory but the accepted normal values are usually between 3.0 and 7.0 mg/dL.
The purines are found in high amounts in animal products such as sardines and liver, pork meat, beef meat, seafood and fish, spinach, green and dried peas, mushrooms, wheat germ and wheat bran, etc.
Drugs that may increase the level of uric acid are aspirin, caffeine, cisplatin, diuretics, nicotinic acid, methyldopa, diazoxide, alcohol, epinephrine, levodopa, theophylline, ascorbic acid and ethambutol.
High levels of uric acid may be due to alcoholism, acidosis, gout, leukemia, renal failure, hypoparathyroidism, chemotherapy side-effect, lead poisoning, diabetes; low levels of acid uric may be due to Wilson’s disease, Fanconi syndrome, low purine diet or syndrome of inappropriate antidiuretic hormone secretion or SIADH.
Studies have also shown that the uric acid may have a certain influence on the prostate cancer and its apparition and development.
Cancer is regarded as an abnormal medical condition, developing because of the heavy influence of certain factors that allow the multiplication of the cancer cells and the bad functioning of the mitosis and the apoptotic reaction.
The spreading process is rather slow, the tumor doubling its size once every four years and because of this, the survival rate of five years after the initial diagnose is of about ninety eight percent.
The cancerous cells tend to outlive the normal cells and cause their rapid death; a primary tumor is, in the first stages of cancer, organ-confined but without any proper treatment it will eventually spread to some other surrounding areas or to far distance regions of the body and create some other small and secondary tumors.
These general features of cancer also describe the prostate cancer. The spreading process is done through the lymph system and bloodstream and the malignant tumor can be detected in the early stages only with the help of the screening tests and for a more accurate result, the prostate biopsy.
There are certain factors such as the genetic inheritance, age, race, working environment, alimentation that are to be blamed for the apparition of a prostate cancer and because of that the same type of cancer will develop at different stages, in different periods of time with some different treatment results or medical side-effects in different people.
The screening tests include the digital rectal exam, an examination which sounds and is rather unpleasant but accurate enough to determine the size of the prostate and the prostate specific antigen blood test which is a tumor marker and indicates the levels of the prostate specific antigen which should be low in normal circumstances. The results of the screening tests have to be interpreted by doctors and depending on them, the medical specialist will recommend some future investigations.
This is the moment when the prostate biopsy comes in handy, complemented by some newer methods of detection such as the nomogram or the prostate mapping. If cancer is diagnosed, the grading process and the staging system such as the TNM, tumor, nodes and metastatic system or its alternative, the Whitmore-Jewett staging system, will help determine the exact characteristics of the identified prostate cancer, because it is well known the fact that each cancer is unique, even though you are referring to the same type of cancer.
The prognosis for the outcome of the prostate cancer is not that optimistic. The prostate cancer still remains the second most dangerous type of cancer, in America only the lung cancer causes more deaths while all around the world, each year, one in six men gets to be diagnosed with a prostate cancer.
Seek for a doctor’s advice and consult him about what foods should be avoided if a prostate cancer is diagnosed and on what products should you built yourself a future nutritional diet.
<-336x280 Large Rectangle - center->
If the uric acid is produced in high levels, a situation known as hyperuricemia, and if it is not removed enough of it will lead to the apparition of certain diseases. Several blood tests indicate the potential level of the uric acid in the body. The normal values of the amount of uric acid identified with the blood tests may vary slightly from laboratory to laboratory but the accepted normal values are usually between 3.0 and 7.0 mg/dL.
The purines are found in high amounts in animal products such as sardines and liver, pork meat, beef meat, seafood and fish, spinach, green and dried peas, mushrooms, wheat germ and wheat bran, etc.
Drugs that may increase the level of uric acid are aspirin, caffeine, cisplatin, diuretics, nicotinic acid, methyldopa, diazoxide, alcohol, epinephrine, levodopa, theophylline, ascorbic acid and ethambutol.
High levels of uric acid may be due to alcoholism, acidosis, gout, leukemia, renal failure, hypoparathyroidism, chemotherapy side-effect, lead poisoning, diabetes; low levels of acid uric may be due to Wilson’s disease, Fanconi syndrome, low purine diet or syndrome of inappropriate antidiuretic hormone secretion or SIADH.
Studies have also shown that the uric acid may have a certain influence on the prostate cancer and its apparition and development.
Cancer is regarded as an abnormal medical condition, developing because of the heavy influence of certain factors that allow the multiplication of the cancer cells and the bad functioning of the mitosis and the apoptotic reaction.
The spreading process is rather slow, the tumor doubling its size once every four years and because of this, the survival rate of five years after the initial diagnose is of about ninety eight percent.
The cancerous cells tend to outlive the normal cells and cause their rapid death; a primary tumor is, in the first stages of cancer, organ-confined but without any proper treatment it will eventually spread to some other surrounding areas or to far distance regions of the body and create some other small and secondary tumors.
These general features of cancer also describe the prostate cancer. The spreading process is done through the lymph system and bloodstream and the malignant tumor can be detected in the early stages only with the help of the screening tests and for a more accurate result, the prostate biopsy.
There are certain factors such as the genetic inheritance, age, race, working environment, alimentation that are to be blamed for the apparition of a prostate cancer and because of that the same type of cancer will develop at different stages, in different periods of time with some different treatment results or medical side-effects in different people.
The screening tests include the digital rectal exam, an examination which sounds and is rather unpleasant but accurate enough to determine the size of the prostate and the prostate specific antigen blood test which is a tumor marker and indicates the levels of the prostate specific antigen which should be low in normal circumstances. The results of the screening tests have to be interpreted by doctors and depending on them, the medical specialist will recommend some future investigations.
This is the moment when the prostate biopsy comes in handy, complemented by some newer methods of detection such as the nomogram or the prostate mapping. If cancer is diagnosed, the grading process and the staging system such as the TNM, tumor, nodes and metastatic system or its alternative, the Whitmore-Jewett staging system, will help determine the exact characteristics of the identified prostate cancer, because it is well known the fact that each cancer is unique, even though you are referring to the same type of cancer.
The prognosis for the outcome of the prostate cancer is not that optimistic. The prostate cancer still remains the second most dangerous type of cancer, in America only the lung cancer causes more deaths while all around the world, each year, one in six men gets to be diagnosed with a prostate cancer.
Seek for a doctor’s advice and consult him about what foods should be avoided if a prostate cancer is diagnosed and on what products should you built yourself a future nutritional diet.
Bone Cancer Survival Rate From Prostate Cancer
Published on May 26 2010, in the categories: Statistics of Survival Rates
Every year, all around the world, one in six men gets to be diagnosed with a prostate cancer while in America, the prostate cancer is on the second place, after the lung cancer, responsible for the deaths of hundreds of men.
<-336x280 Large Rectangle - center->
The prostate is a male specific organ, responsible with the making of the semen, so usually, after the age of forty, when all men experience the so-called “andropause” or “male menopause”, any hormonal problems and unbalances may lead to the apparition of some prostate disorders and diseases such as prostatitis, the benign prostatic hyperplasia and cancer.
Cancer is diagnosed only when the existence of cancer cells or a malignant tumor is detected and since there are no early symptoms to make this disease noticeable in its early stages, the screening tests are often recommended.
The results of the screening tests have to be interpreted by doctors because they don’t give an accurate diagnose whether the cancer exists or not or if it is organ confined or locally advanced. For example, with the digital rectal exam the physician will palpate with a gloved finger inserted into the rectum the size of the prostate and determine whether an abnormal lump or hardness is felt on the surface of the presumably infected gland and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal circumstances, making this test a tumor and biological marker.
If cancer is detected early, the survival rates can only increase, especially if the patient responds well to the prescribed treatment.
An accurate diagnose can be obtained only with the help of the prostate biopsy complemented by a nomogram or the prostate mapping method.
The prognosis is relevant in the cases when doctors wish to determine the characteristics of a cancer; unfortunately, each cancer is unique and that means that the same type of cancer could develop in different periods of time, at different stages in different patients, with different treatment results, making the prognosis challenging.
The chances of fifteen year survival rate are of seventy seven percent and usually after this period of time the survival rates tend to stabilize; the lifetime probability to develop cancer is of sixteen percent and if cancer is detected early there is a ninety eight percent chance of survival at least for five years after the initial diagnose.
If cancer is detected, the grading and staging will be very important for prescribing the right form of treatment. The staging is done with the Whitmore-Jewett staging system or the TNM, tumor, nodes and metastatic system; according to these systems there are four stages of prostate cancer the last being the stage of metastatic cancer.
The apparition of a prostate cancer depends on certain factors such as the aging process, race and genetic inheritance and even the working environment; the progression of a prostate cancer is done steadily, the tumor doubling its size once every four years.
The spreading process is done through the lymph system and bloodstream until the primary tumor, in the first stage being organ confined, affects the surrounding organs and tissues and gives birth to other secondary and small tumors. These tumors can become metastatic and affect vital organs such as the liver, lungs and brain.
The prostate cancer has the predilection of affecting gravely the bone structures so even though the signs of a prostate cancer tend to appear only when the cancer beings its evolution the bones can be affected even in the first stages. If some unusual bone pains are felt this is a definitive sign that a person must immediately contact his personal doctor. The radionuclide bone scans, the coaxial tomography or the magnetic resonance imaging or MRI can confirm if the cancer has spread to the bone system or not and in general the bone lesions are osteoblastic, osteolytic or mixed.
The two major prognosis for the outcome of the prostate cancer indicate a challenging treatment or the patient will respond well to the treatment; for the locally advanced cancer the survival rates can be prolonged but the metastatic cancer will prove merciless and the chances of survival, even with a proper treatment such as the hormone therapy or radiotherapy, will drop at low levels.
<-336x280 Large Rectangle - center->
The prostate is a male specific organ, responsible with the making of the semen, so usually, after the age of forty, when all men experience the so-called “andropause” or “male menopause”, any hormonal problems and unbalances may lead to the apparition of some prostate disorders and diseases such as prostatitis, the benign prostatic hyperplasia and cancer.
Cancer is diagnosed only when the existence of cancer cells or a malignant tumor is detected and since there are no early symptoms to make this disease noticeable in its early stages, the screening tests are often recommended.
The results of the screening tests have to be interpreted by doctors because they don’t give an accurate diagnose whether the cancer exists or not or if it is organ confined or locally advanced. For example, with the digital rectal exam the physician will palpate with a gloved finger inserted into the rectum the size of the prostate and determine whether an abnormal lump or hardness is felt on the surface of the presumably infected gland and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal circumstances, making this test a tumor and biological marker.
If cancer is detected early, the survival rates can only increase, especially if the patient responds well to the prescribed treatment.
An accurate diagnose can be obtained only with the help of the prostate biopsy complemented by a nomogram or the prostate mapping method.
The prognosis is relevant in the cases when doctors wish to determine the characteristics of a cancer; unfortunately, each cancer is unique and that means that the same type of cancer could develop in different periods of time, at different stages in different patients, with different treatment results, making the prognosis challenging.
The chances of fifteen year survival rate are of seventy seven percent and usually after this period of time the survival rates tend to stabilize; the lifetime probability to develop cancer is of sixteen percent and if cancer is detected early there is a ninety eight percent chance of survival at least for five years after the initial diagnose.
If cancer is detected, the grading and staging will be very important for prescribing the right form of treatment. The staging is done with the Whitmore-Jewett staging system or the TNM, tumor, nodes and metastatic system; according to these systems there are four stages of prostate cancer the last being the stage of metastatic cancer.
The apparition of a prostate cancer depends on certain factors such as the aging process, race and genetic inheritance and even the working environment; the progression of a prostate cancer is done steadily, the tumor doubling its size once every four years.
The spreading process is done through the lymph system and bloodstream until the primary tumor, in the first stage being organ confined, affects the surrounding organs and tissues and gives birth to other secondary and small tumors. These tumors can become metastatic and affect vital organs such as the liver, lungs and brain.
The prostate cancer has the predilection of affecting gravely the bone structures so even though the signs of a prostate cancer tend to appear only when the cancer beings its evolution the bones can be affected even in the first stages. If some unusual bone pains are felt this is a definitive sign that a person must immediately contact his personal doctor. The radionuclide bone scans, the coaxial tomography or the magnetic resonance imaging or MRI can confirm if the cancer has spread to the bone system or not and in general the bone lesions are osteoblastic, osteolytic or mixed.
The two major prognosis for the outcome of the prostate cancer indicate a challenging treatment or the patient will respond well to the treatment; for the locally advanced cancer the survival rates can be prolonged but the metastatic cancer will prove merciless and the chances of survival, even with a proper treatment such as the hormone therapy or radiotherapy, will drop at low levels.
Having Trouble Pooping A Symptom Of Prostate Cancer
Published on May 26 2010, in the categories: Useful Info
The prostate is a male specific organ, responsible with the making of the semen, so usually, after the age of forty, when all men experience the so-called “andropause” or “male menopause”, any hormonal problems and unbalances may lead to the apparition of some prostate disorders and diseases such as prostatitis, the benign prostatic hyperplasia and cancer.
<-336x280 Large Rectangle - center->
Cancer is diagnosed only when the existence of cancer cells or a malignant tumor is detected and since there are no early symptoms to make this disease noticeable in its early stages, the screening tests are often recommended.
Every year, all around the world, one in six men gets to be diagnosed with a prostate cancer while in America, the prostate cancer is on the second place, after the lung cancer, responsible for the deaths of hundreds of men.
The prognosis is relevant in the cases when doctors wish to determine the characteristics of a cancer; unfortunately, each cancer is unique and that means that the same type of cancer could develop in different periods of time, at different stages in different patients, with different treatment results, making the prognosis challenging.
The two major prognosis for the outcome of the prostate cancer indicate a challenging treatment or the patient will respond well to the treatment; for the locally advanced cancer the survival rates can be prolonged but the metastatic cancer will prove merciless and the chances of survival, even with a proper treatment such as the hormone therapy or radiotherapy, will drop at low levels.
The results of the screening tests have to be interpreted by doctors because they don’t give an accurate diagnose whether the cancer exists or not or if it is organ confined or locally advanced. For example, with the digital rectal exam the physician will palpate with a gloved finger inserted into the rectum the size of the prostate and determine whether an abnormal lump or hardness is felt on the surface of the presumably infected gland and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal circumstances, making this test a tumor and biological marker.
An accurate diagnose can be obtained only with the help of the prostate biopsy complemented by a nomogram or the prostate mapping method.
The spreading process is done through the lymph system and bloodstream until the primary tumor, in the first stage being organ confined, affects the surrounding organs and tissues and gives birth to other secondary and small tumors. These tumors can become metastatic and affect vital organs such as the liver, lungs and brain.
Usually, the common reported signs and symptoms are: ache or abdomen and bone pain, blood in urine or semen, compression of the spine, burning while urinating, painful ejaculation, leg weakness or incontinence, weak or frequent urine stream, burning while urinating, back pains, stiffness, painful ejaculation, pain while urinating.
If you have a problem with pooping that could also mean that you may or may not have a prostate cancer. As I’ve mentioned above, some symptoms can be caused by some other prostate disorders, not only cancer, and the enlargement of the prostate caused by the benign prostatic hyperplasia may affect the activity of pooping.
The best thing is to contact your personal doctors if some of the above mentioned symptoms are reported because detecting the prostate cancer in its early stages can only increase the chances of curing it; the lifetime probability to develop cancer is of sixteen percent and if cancer is detected early there is a ninety eight percent chance of survival at least for five years after the initial diagnose.
<-336x280 Large Rectangle - center->
Cancer is diagnosed only when the existence of cancer cells or a malignant tumor is detected and since there are no early symptoms to make this disease noticeable in its early stages, the screening tests are often recommended.
Every year, all around the world, one in six men gets to be diagnosed with a prostate cancer while in America, the prostate cancer is on the second place, after the lung cancer, responsible for the deaths of hundreds of men.
The prognosis is relevant in the cases when doctors wish to determine the characteristics of a cancer; unfortunately, each cancer is unique and that means that the same type of cancer could develop in different periods of time, at different stages in different patients, with different treatment results, making the prognosis challenging.
The two major prognosis for the outcome of the prostate cancer indicate a challenging treatment or the patient will respond well to the treatment; for the locally advanced cancer the survival rates can be prolonged but the metastatic cancer will prove merciless and the chances of survival, even with a proper treatment such as the hormone therapy or radiotherapy, will drop at low levels.
The results of the screening tests have to be interpreted by doctors because they don’t give an accurate diagnose whether the cancer exists or not or if it is organ confined or locally advanced. For example, with the digital rectal exam the physician will palpate with a gloved finger inserted into the rectum the size of the prostate and determine whether an abnormal lump or hardness is felt on the surface of the presumably infected gland and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal circumstances, making this test a tumor and biological marker.
An accurate diagnose can be obtained only with the help of the prostate biopsy complemented by a nomogram or the prostate mapping method.
The spreading process is done through the lymph system and bloodstream until the primary tumor, in the first stage being organ confined, affects the surrounding organs and tissues and gives birth to other secondary and small tumors. These tumors can become metastatic and affect vital organs such as the liver, lungs and brain.
Usually, the common reported signs and symptoms are: ache or abdomen and bone pain, blood in urine or semen, compression of the spine, burning while urinating, painful ejaculation, leg weakness or incontinence, weak or frequent urine stream, burning while urinating, back pains, stiffness, painful ejaculation, pain while urinating.
If you have a problem with pooping that could also mean that you may or may not have a prostate cancer. As I’ve mentioned above, some symptoms can be caused by some other prostate disorders, not only cancer, and the enlargement of the prostate caused by the benign prostatic hyperplasia may affect the activity of pooping.
The best thing is to contact your personal doctors if some of the above mentioned symptoms are reported because detecting the prostate cancer in its early stages can only increase the chances of curing it; the lifetime probability to develop cancer is of sixteen percent and if cancer is detected early there is a ninety eight percent chance of survival at least for five years after the initial diagnose.
RECENT COMMENTS